FDA Warning Letter — Kelley-Ross & Associates, Inc.

Case 560795 — FEI 3013436443

The FDA took a Warning Letter action against Kelley-Ross & Associates, Inc. on Aug 2, 2018 (Seattle, WA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action details

Facility
Kelley-Ross & Associates, Inc.
Date
Aug 2, 2018
Fiscal Year
2018
Product Type
Drugs
Center
CDER
Location
Seattle, WA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.